11C-GSK189254: A Selective Radioligand for In Vivo Central Nervous System Imaging of Histamine H3 Receptors by PET-Reference-Cited by-同舟云学术

11C-GSK189254: A Selective Radioligand for In Vivo Central Nervous System Imaging of Histamine H3 Receptors by PET

Published:2009-11-12 Issue:12 Volume:50 Page:2064-2072
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Plisson Christophe,Gunn Roger N.,Cunningham Vincent J.,Bender Dirk,Salinas Cristian A.,Medhurst Andrew D.,Roberts Jennifer C.,Laruelle Marc,Gee Antony D.

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference36 articles.

1. A detailed mapping of the histamine H3 receptor and its gene transcripts in rat brain

2. Distribution and Modulation of Histamine H3 Receptors in Basal Ganglia and Frontal Cortex of Healthy Controls and Patients with Parkinson's Disease

3. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor

4. Histamine H3 receptors modulate the release of [3H]-acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3 receptor subtypes

5. Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Age and BMI on Histamine H3 Receptor Availability in Healthy Humans;2024-05-15

2. Histaminergic neurotransmission in aging and Alzheimer's disease: A review of therapeutic opportunities and gaps;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2023-04

3. Binding of the Dual-Action Anti-Parkinsonian Drug AG-0029 to Dopamine D₂ and Histamine H₃ Receptors: A PET Study in Healthy Rats;Molecular Pharmaceutics;2022-06-22

4. Beyond monoamines: I. Novel targets and radiotracers for Positron emission tomography imaging in psychiatric disorders;Journal of Neurochemistry;2022-05-10

5. Pharmacokinetic Modeling of [¹¹C]GSK-189254, PET Tracer Targeting H₃ Receptors, in Rat Brain;Molecular Pharmaceutics;2022-02-16